

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.41467285 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41467285 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.87933340 |
| 4 | type I interferon signaling pathway (GO:0060337) | 4.54169265 |
| 5 | cellular response to type I interferon (GO:0071357) | 4.54169265 |
| 6 | response to type I interferon (GO:0034340) | 4.52675466 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.27713452 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.27713452 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.27713452 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.27713452 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.27713452 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.27713452 |
| 13 | DNA strand elongation (GO:0022616) | 4.21267031 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.11732182 |
| 15 | establishment of integrated proviral latency (GO:0075713) | 4.05071692 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.02765487 |
| 17 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.95887034 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 3.90449697 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.85594135 |
| 20 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.84215819 |
| 21 | response to interferon-alpha (GO:0035455) | 3.81566420 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.73990910 |
| 23 | establishment of viral latency (GO:0019043) | 3.62466098 |
| 24 | cellular response to virus (GO:0098586) | 3.54452548 |
| 25 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.53952835 |
| 26 | positive regulation of interferon-beta production (GO:0032728) | 3.53589751 |
| 27 | B cell mediated immunity (GO:0019724) | 3.51788809 |
| 28 | mitotic chromosome condensation (GO:0007076) | 3.48221703 |
| 29 | T cell migration (GO:0072678) | 3.42161130 |
| 30 | cellular response to interferon-alpha (GO:0035457) | 3.41632113 |
| 31 | DNA topological change (GO:0006265) | 3.40196933 |
| 32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.31941658 |
| 33 | negative regulation of ligase activity (GO:0051352) | 3.31941658 |
| 34 | response to peptidoglycan (GO:0032494) | 3.31877599 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.30444660 |
| 36 | DNA replication initiation (GO:0006270) | 3.29119162 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28902530 |
| 38 | ribosome assembly (GO:0042255) | 3.28777025 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 3.27465453 |
| 40 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.26548694 |
| 41 | mitotic sister chromatid segregation (GO:0000070) | 3.23798852 |
| 42 | cellular response to interferon-beta (GO:0035458) | 3.23092500 |
| 43 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.21447447 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19776230 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 3.19721438 |
| 46 | telomere maintenance via recombination (GO:0000722) | 3.17234150 |
| 47 | mitotic metaphase plate congression (GO:0007080) | 3.16554132 |
| 48 | natural killer cell mediated immunity (GO:0002228) | 3.16359789 |
| 49 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.16359789 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.14418875 |
| 51 | protein maturation by protein folding (GO:0022417) | 3.08794299 |
| 52 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.05025663 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.00736312 |
| 54 | response to host immune response (GO:0052572) | 3.00736312 |
| 55 | regulation of translational termination (GO:0006449) | 3.00278190 |
| 56 | regulation of RIG-I signaling pathway (GO:0039535) | 3.00194164 |
| 57 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.00135527 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.97806871 |
| 59 | cellular response to zinc ion (GO:0071294) | 2.95331803 |
| 60 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.93037411 |
| 61 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.92863415 |
| 62 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.92755052 |
| 63 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.92755052 |
| 64 | mitotic recombination (GO:0006312) | 2.92178293 |
| 65 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.92080233 |
| 66 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.92080233 |
| 67 | regulation of response to interferon-gamma (GO:0060330) | 2.91609889 |
| 68 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.91398588 |
| 69 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.91398588 |
| 70 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.91398588 |
| 71 | protein localization to chromosome, centromeric region (GO:0071459) | 2.91352548 |
| 72 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.90107243 |
| 73 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.90023698 |
| 74 | response to interferon-beta (GO:0035456) | 2.89502745 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.87982991 |
| 76 | ribosome biogenesis (GO:0042254) | 2.86668521 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85180867 |
| 78 | cellular response to interferon-gamma (GO:0071346) | 2.84721529 |
| 79 | proteasome assembly (GO:0043248) | 2.83434721 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 2.83279566 |
| 81 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.82935419 |
| 82 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.82693513 |
| 83 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.82150140 |
| 84 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81249616 |
| 85 | response to host (GO:0075136) | 2.81249616 |
| 86 | response to host defenses (GO:0052200) | 2.81249616 |
| 87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80376428 |
| 88 | positive regulation of ligase activity (GO:0051351) | 2.78801819 |
| 89 | IMP biosynthetic process (GO:0006188) | 2.78310531 |
| 90 | sister chromatid segregation (GO:0000819) | 2.77182695 |
| 91 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.74753480 |
| 92 | regulation of interferon-beta production (GO:0032648) | 2.72880910 |
| 93 | telomere maintenance via telomere lengthening (GO:0010833) | 2.71956760 |
| 94 | natural killer cell differentiation (GO:0001779) | 2.71898957 |
| 95 | negative regulation of interleukin-12 production (GO:0032695) | 2.71608312 |
| 96 | purine nucleobase biosynthetic process (GO:0009113) | 2.71238771 |
| 97 | defense response to virus (GO:0051607) | 2.70770861 |
| 98 | response to muramyl dipeptide (GO:0032495) | 2.70215650 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69710643 |
| 100 | negative regulation of mRNA processing (GO:0050686) | 2.67823876 |
| 101 | neutrophil activation involved in immune response (GO:0002283) | 2.67197230 |
| 102 | maturation of SSU-rRNA (GO:0030490) | 2.67021255 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 2.65994205 |
| 104 | regulation of ligase activity (GO:0051340) | 2.65856052 |
| 105 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.64759596 |
| 106 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.62775159 |
| 107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62183812 |
| 108 | mitotic nuclear envelope disassembly (GO:0007077) | 2.60630700 |
| 109 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.60018328 |
| 110 | rRNA transcription (GO:0009303) | 2.58937350 |
| 111 | heterochromatin organization (GO:0070828) | 2.57592749 |
| 112 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.57534650 |
| 113 | negative regulation of mRNA metabolic process (GO:1903312) | 2.57248415 |
| 114 | viral mRNA export from host cell nucleus (GO:0046784) | 2.57050229 |
| 115 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.55440738 |
| 116 | cell cycle G1/S phase transition (GO:0044843) | 2.55440738 |
| 117 | nuclear pore organization (GO:0006999) | 2.54678987 |
| 118 | defense response to protozoan (GO:0042832) | 2.54650619 |
| 119 | nuclear envelope reassembly (GO:0031468) | 2.54406943 |
| 120 | mitotic nuclear envelope reassembly (GO:0007084) | 2.54406943 |
| 121 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.54028977 |
| 122 | protein complex localization (GO:0031503) | 2.53634996 |
| 123 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.53036968 |
| 124 | base-excision repair (GO:0006284) | 2.52056911 |
| 125 | negative regulation of viral process (GO:0048525) | 2.51810186 |
| 126 | pentose-phosphate shunt (GO:0006098) | 2.51727213 |
| 127 | regulation of helicase activity (GO:0051095) | 2.50546514 |
| 128 | histone arginine methylation (GO:0034969) | 2.50081403 |
| 129 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.49334862 |
| 130 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.48076651 |
| 131 | DNA ligation (GO:0006266) | 2.47883340 |
| 132 | nucleobase biosynthetic process (GO:0046112) | 2.47873020 |
| 133 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.47834732 |
| 134 | regulation of necroptotic process (GO:0060544) | 2.47487155 |
| 135 | spliceosomal snRNP assembly (GO:0000387) | 2.47356376 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.47207306 |
| 137 | COPI coating of Golgi vesicle (GO:0048205) | 2.47170206 |
| 138 | Golgi transport vesicle coating (GO:0048200) | 2.47170206 |
| 139 | cellular response to interleukin-4 (GO:0071353) | 2.45936253 |
| 140 | regulation of chemokine biosynthetic process (GO:0045073) | 2.45076157 |
| 141 | regulation of viral genome replication (GO:0045069) | 2.45006769 |
| 142 | nuclear pore complex assembly (GO:0051292) | 2.44136295 |
| 143 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.43528775 |
| 144 | NADPH regeneration (GO:0006740) | 2.43430860 |
| 145 | positive regulation of type I interferon production (GO:0032481) | 2.42978498 |
| 146 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.42934082 |
| 147 | leukocyte aggregation (GO:0070486) | 2.42902618 |
| 148 | positive regulation of type 2 immune response (GO:0002830) | 2.42733968 |
| 149 | metaphase plate congression (GO:0051310) | 2.42661521 |
| 150 | negative regulation of chromosome segregation (GO:0051985) | 2.42053761 |
| 151 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.41632477 |
| 152 | membrane disassembly (GO:0030397) | 2.40730776 |
| 153 | nuclear envelope disassembly (GO:0051081) | 2.40730776 |
| 154 | response to interferon-gamma (GO:0034341) | 2.40538251 |
| 155 | DNA replication checkpoint (GO:0000076) | 2.39859924 |
| 156 | DNA unwinding involved in DNA replication (GO:0006268) | 2.39623860 |
| 157 | positive regulation of cell cycle arrest (GO:0071158) | 2.39311755 |
| 158 | negative regulation of RNA splicing (GO:0033119) | 2.39027053 |
| 159 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.38982536 |
| 160 | IMP metabolic process (GO:0046040) | 2.38114982 |
| 161 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.37766674 |
| 162 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.37636852 |
| 163 | lymphocyte mediated immunity (GO:0002449) | 2.36589851 |
| 164 | formation of translation preinitiation complex (GO:0001731) | 2.36462846 |
| 165 | negative regulation of protein ubiquitination (GO:0031397) | 2.36092958 |
| 166 | regulation of spindle organization (GO:0090224) | 2.35534693 |
| 167 | establishment of chromosome localization (GO:0051303) | 2.35380215 |
| 168 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.34929081 |
| 169 | negative regulation of sister chromatid segregation (GO:0033046) | 2.34887257 |
| 170 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.34887257 |
| 171 | positive regulation of isotype switching (GO:0045830) | 2.34337512 |
| 172 | positive regulation of humoral immune response (GO:0002922) | 2.32373960 |
| 173 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.32196484 |
| 174 | cellular response to dsRNA (GO:0071359) | 2.32055523 |
| 175 | negative thymic T cell selection (GO:0045060) | 2.31009014 |
| 176 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.30800880 |
| 177 | respiratory burst (GO:0045730) | 2.30507017 |
| 178 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.30153495 |
| 179 | negative regulation by host of viral transcription (GO:0043922) | 2.29510855 |
| 180 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.29407159 |
| 181 | response to protozoan (GO:0001562) | 2.27609977 |
| 182 | positive regulation of antigen processing and presentation (GO:0002579) | 2.26905566 |
| 183 | granulocyte activation (GO:0036230) | 2.26733707 |
| 184 | protein localization to kinetochore (GO:0034501) | 2.25982141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.00973938 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.62510356 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.22103428 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.57853828 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.55532825 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.32835635 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.19174687 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.53290627 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.52539689 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.43797106 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.42791572 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.35876884 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35755668 |
| 14 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.34447473 |
| 15 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19124183 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.17123704 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15611463 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.14419656 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10394930 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09501973 |
| 21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.98590466 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96721151 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.95456806 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94990002 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93540081 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.91859672 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86264594 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84610173 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82089490 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.81727589 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.80540361 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76440761 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.74671381 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71657955 |
| 35 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.69547327 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65126168 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64674586 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63767764 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61988069 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61109385 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60257464 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.58143539 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.55744232 |
| 44 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.54770550 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53854262 |
| 46 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.52555808 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48977944 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47965330 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47510963 |
| 50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.46070090 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45458556 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42522412 |
| 53 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.42455030 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42069512 |
| 55 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41364126 |
| 56 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.40517118 |
| 57 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.40184948 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34453983 |
| 59 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34143285 |
| 60 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33950259 |
| 61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.32162787 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.29095639 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29094210 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26412429 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25541802 |
| 66 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25191598 |
| 67 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24845998 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24553318 |
| 69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24191555 |
| 70 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23846102 |
| 71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23410470 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23125574 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21746561 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20810653 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19507864 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19342819 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19112853 |
| 78 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18229888 |
| 79 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18075819 |
| 80 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17245101 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15447366 |
| 82 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15361119 |
| 83 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.14320529 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14213850 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13695980 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13056591 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12088548 |
| 88 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11796367 |
| 89 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09864174 |
| 90 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09454263 |
| 91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09116827 |
| 92 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07791810 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07296799 |
| 94 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06115743 |
| 95 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06115743 |
| 96 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06115743 |
| 97 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06097905 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05630294 |
| 99 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05299445 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04600933 |
| 101 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04586679 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04413334 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03808595 |
| 104 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03240369 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02889531 |
| 106 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02123251 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01880664 |
| 108 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99833085 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98947099 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98789347 |
| 111 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.98596973 |
| 112 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.97762226 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97702694 |
| 114 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97470756 |
| 115 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.96238115 |
| 116 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95968450 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95955019 |
| 118 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95762444 |
| 119 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95614935 |
| 120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94893253 |
| 121 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94671096 |
| 122 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94345247 |
| 123 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94248985 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93350593 |
| 125 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92910222 |
| 126 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92389275 |
| 127 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92376322 |
| 128 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91845592 |
| 129 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91726199 |
| 130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91628704 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90924767 |
| 132 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89853598 |
| 133 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.89623951 |
| 134 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89483342 |
| 135 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88483597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.68920700 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.03165434 |
| 3 | MP0009785_altered_susceptibility_to | 3.02335809 |
| 4 | MP0000685_abnormal_immune_system | 2.95427797 |
| 5 | MP0003436_decreased_susceptibility_to | 2.83048486 |
| 6 | MP0001800_abnormal_humoral_immune | 2.58115964 |
| 7 | MP0005387_immune_system_phenotype | 2.56326632 |
| 8 | MP0001790_abnormal_immune_system | 2.56326632 |
| 9 | MP0003303_peritoneal_inflammation | 2.51663693 |
| 10 | MP0006082_CNS_inflammation | 2.51135630 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.48939805 |
| 12 | MP0005025_abnormal_response_to | 2.47141003 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.42203969 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.36642662 |
| 15 | MP0008057_abnormal_DNA_replication | 2.34285684 |
| 16 | MP0005671_abnormal_response_to | 2.33797969 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.29562002 |
| 18 | MP0002723_abnormal_immune_serum | 2.28379581 |
| 19 | MP0003724_increased_susceptibility_to | 2.20644619 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.18690888 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.14343146 |
| 22 | MP0010307_abnormal_tumor_latency | 2.13382495 |
| 23 | MP0003693_abnormal_embryo_hatching | 2.12796980 |
| 24 | MP0008260_abnormal_autophagy | 2.12780695 |
| 25 | MP0001819_abnormal_immune_cell | 2.12062171 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.09772957 |
| 27 | MP0002419_abnormal_innate_immunity | 2.08945385 |
| 28 | MP0002398_abnormal_bone_marrow | 2.04810419 |
| 29 | MP0009278_abnormal_bone_marrow | 2.03713720 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.00052181 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.88596112 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.84747444 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.84491096 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.84491096 |
| 35 | MP0003786_premature_aging | 1.82664859 |
| 36 | MP0000716_abnormal_immune_system | 1.81646257 |
| 37 | MP0005451_abnormal_body_composition | 1.81584489 |
| 38 | MP0003077_abnormal_cell_cycle | 1.81504663 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.80131699 |
| 40 | MP0004947_skin_inflammation | 1.77226716 |
| 41 | MP0002405_respiratory_system_inflammati | 1.76965112 |
| 42 | MP0000858_altered_metastatic_potential | 1.74442976 |
| 43 | * MP0003111_abnormal_nucleus_morphology | 1.67734747 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.65696940 |
| 45 | MP0002722_abnormal_immune_system | 1.65581191 |
| 46 | MP0003448_altered_tumor_morphology | 1.65544707 |
| 47 | MP0004510_myositis | 1.62971801 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.62046041 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.61090187 |
| 50 | MP0002429_abnormal_blood_cell | 1.61012573 |
| 51 | MP0002006_tumorigenesis | 1.60224828 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.58285123 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.51214910 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.48554276 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.48173512 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.46324946 |
| 57 | MP0001853_heart_inflammation | 1.41641186 |
| 58 | MP0008058_abnormal_DNA_repair | 1.39108482 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.36171427 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.35279758 |
| 61 | MP0008007_abnormal_cellular_replicative | 1.29390716 |
| 62 | MP0005501_abnormal_skin_physiology | 1.26198813 |
| 63 | MP0009764_decreased_sensitivity_to | 1.25641189 |
| 64 | MP0008469_abnormal_protein_level | 1.23753070 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.23021627 |
| 66 | MP0005023_abnormal_wound_healing | 1.21596091 |
| 67 | MP0000490_abnormal_crypts_of | 1.20989220 |
| 68 | MP0002796_impaired_skin_barrier | 1.20297945 |
| 69 | MP0000350_abnormal_cell_proliferation | 1.17935070 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 1.17926820 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.17027174 |
| 72 | MP0001849_ear_inflammation | 1.12417455 |
| 73 | MP0009672_abnormal_birth_weight | 1.11564364 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.08975207 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 1.05610674 |
| 76 | MP0001730_embryonic_growth_arrest | 1.02895587 |
| 77 | MP0000343_altered_response_to | 1.01898617 |
| 78 | MP0000358_abnormal_cell_content/ | 1.00778910 |
| 79 | MP0002254_reproductive_system_inflammat | 0.99586741 |
| 80 | MP0009840_abnormal_foam_cell | 0.99483451 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.99009469 |
| 82 | MP0002132_abnormal_respiratory_system | 0.96812567 |
| 83 | * MP0000313_abnormal_cell_death | 0.96741455 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.94786324 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.93872105 |
| 86 | MP0005384_cellular_phenotype | 0.91298278 |
| 87 | MP0001915_intracranial_hemorrhage | 0.90769924 |
| 88 | MP0003075_altered_response_to | 0.90586463 |
| 89 | MP0000678_abnormal_parathyroid_gland | 0.89701412 |
| 90 | MP0005310_abnormal_salivary_gland | 0.88821579 |
| 91 | MP0003315_abnormal_perineum_morphology | 0.85724471 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.85588269 |
| 93 | MP0005390_skeleton_phenotype | 0.85302508 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.84466523 |
| 95 | MP0001727_abnormal_embryo_implantation | 0.83495429 |
| 96 | MP0003941_abnormal_skin_development | 0.82933466 |
| 97 | * MP0002086_abnormal_extraembryonic_tissu | 0.82453607 |
| 98 | MP0003718_maternal_effect | 0.81652462 |
| 99 | MP0001873_stomach_inflammation | 0.80927778 |
| 100 | MP0005670_abnormal_white_adipose | 0.76393854 |
| 101 | MP0006054_spinal_hemorrhage | 0.76143065 |
| 102 | * MP0002085_abnormal_embryonic_tissue | 0.74863275 |
| 103 | * MP0001697_abnormal_embryo_size | 0.74600204 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.74338060 |
| 105 | MP0003186_abnormal_redox_activity | 0.73019049 |
| 106 | MP0000371_diluted_coat_color | 0.71927701 |
| 107 | * MP0002080_prenatal_lethality | 0.71436808 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70666280 |
| 109 | MP0005621_abnormal_cell_physiology | 0.70431726 |
| 110 | * MP0005380_embryogenesis_phenotype | 0.70382709 |
| 111 | * MP0001672_abnormal_embryogenesis/_devel | 0.70382709 |
| 112 | * MP0003984_embryonic_growth_retardation | 0.69934280 |
| 113 | MP0002933_joint_inflammation | 0.69630770 |
| 114 | MP0009763_increased_sensitivity_to | 0.68962707 |
| 115 | * MP0002088_abnormal_embryonic_growth/wei | 0.68743525 |
| 116 | MP0008932_abnormal_embryonic_tissue | 0.67128404 |
| 117 | MP0004197_abnormal_fetal_growth/weight/ | 0.65566786 |
| 118 | MP0008438_abnormal_cutaneous_collagen | 0.64685587 |
| 119 | MP0003091_abnormal_cell_migration | 0.64561724 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.62688446 |
| 121 | MP0003866_abnormal_defecation | 0.62288218 |
| 122 | MP0001293_anophthalmia | 0.61707900 |
| 123 | MP0008877_abnormal_DNA_methylation | 0.59216785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.70153309 |
| 2 | Nasal polyposis (HP:0100582) | 4.58172749 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50361546 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.34118001 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.02631219 |
| 6 | Chronic otitis media (HP:0000389) | 3.99348075 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 3.96522125 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.96491480 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 3.88727185 |
| 10 | Recurrent bronchitis (HP:0002837) | 3.78480202 |
| 11 | Recurrent viral infections (HP:0004429) | 3.70210200 |
| 12 | Aplastic anemia (HP:0001915) | 3.55840977 |
| 13 | Myositis (HP:0100614) | 3.51649439 |
| 14 | Increased IgM level (HP:0003496) | 3.45686088 |
| 15 | Microvesicular hepatic steatosis (HP:0001414) | 3.41300295 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.32982581 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.31568884 |
| 18 | Abnormal gallbladder physiology (HP:0012438) | 3.19636123 |
| 19 | Cholecystitis (HP:0001082) | 3.19636123 |
| 20 | Rough bone trabeculation (HP:0100670) | 3.06046014 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98860140 |
| 22 | Orchitis (HP:0100796) | 2.97301867 |
| 23 | Basal ganglia calcification (HP:0002135) | 2.86628046 |
| 24 | Porencephaly (HP:0002132) | 2.85996235 |
| 25 | Vasculitis (HP:0002633) | 2.85575319 |
| 26 | Abnormality of T cells (HP:0002843) | 2.84418590 |
| 27 | Pustule (HP:0200039) | 2.82332659 |
| 28 | Abnormality of T cell number (HP:0011839) | 2.80405336 |
| 29 | Multiple enchondromatosis (HP:0005701) | 2.79076141 |
| 30 | Ragged-red muscle fibers (HP:0003200) | 2.74723160 |
| 31 | T lymphocytopenia (HP:0005403) | 2.72843767 |
| 32 | Cleft eyelid (HP:0000625) | 2.72760152 |
| 33 | Progressive muscle weakness (HP:0003323) | 2.70611205 |
| 34 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.66819677 |
| 35 | Emphysema (HP:0002097) | 2.63930727 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.62329673 |
| 37 | Cellulitis (HP:0100658) | 2.61583901 |
| 38 | Agnosia (HP:0010524) | 2.60441600 |
| 39 | Hypertensive crisis (HP:0100735) | 2.60416530 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 2.55847410 |
| 41 | Stomatitis (HP:0010280) | 2.55641542 |
| 42 | Hypergammaglobulinemia (HP:0010702) | 2.53903336 |
| 43 | Recurrent skin infections (HP:0001581) | 2.49619590 |
| 44 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.44146527 |
| 45 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.44146527 |
| 46 | Single umbilical artery (HP:0001195) | 2.44146527 |
| 47 | Degeneration of anterior horn cells (HP:0002398) | 2.43781138 |
| 48 | Abnormality of the anterior horn cell (HP:0006802) | 2.43781138 |
| 49 | Abnormality of the umbilical cord (HP:0010881) | 2.43179866 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.40413782 |
| 51 | Trismus (HP:0000211) | 2.40204145 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 2.39098609 |
| 53 | Optic neuritis (HP:0100653) | 2.39098609 |
| 54 | Gingivitis (HP:0000230) | 2.39097777 |
| 55 | Bronchitis (HP:0012387) | 2.37829311 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.36821157 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.34832372 |
| 58 | Increased serum ferritin (HP:0003281) | 2.33005243 |
| 59 | Abnormal trabecular bone morphology (HP:0100671) | 2.30524114 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.30499347 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.30499347 |
| 62 | Combined immunodeficiency (HP:0005387) | 2.28664394 |
| 63 | Progressive external ophthalmoplegia (HP:0000590) | 2.27339076 |
| 64 | Pancytopenia (HP:0001876) | 2.26951915 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.26865025 |
| 66 | Leukocytosis (HP:0001974) | 2.26819101 |
| 67 | Selective tooth agenesis (HP:0001592) | 2.24896140 |
| 68 | Entropion (HP:0000621) | 2.24471227 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.23551599 |
| 70 | Lymphopenia (HP:0001888) | 2.23545897 |
| 71 | Obstructive lung disease (HP:0006536) | 2.20532042 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.20532042 |
| 73 | Oral leukoplakia (HP:0002745) | 2.18750931 |
| 74 | Chromsome breakage (HP:0040012) | 2.17326669 |
| 75 | Lymphoma (HP:0002665) | 2.17211270 |
| 76 | IgA deficiency (HP:0002720) | 2.14482319 |
| 77 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.14400704 |
| 78 | Chronic sinusitis (HP:0011109) | 2.13147048 |
| 79 | Thrombocytosis (HP:0001894) | 2.13079197 |
| 80 | Premature ovarian failure (HP:0008209) | 2.11159236 |
| 81 | Squamous cell carcinoma (HP:0002860) | 2.10126927 |
| 82 | IgM deficiency (HP:0002850) | 2.09130902 |
| 83 | Seborrheic dermatitis (HP:0001051) | 2.09107324 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.08769945 |
| 85 | Eosinophilia (HP:0001880) | 2.07769596 |
| 86 | Poor head control (HP:0002421) | 2.05971020 |
| 87 | Agammaglobulinemia (HP:0004432) | 2.05729355 |
| 88 | Petechiae (HP:0000967) | 2.01161674 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01100726 |
| 90 | Meningitis (HP:0001287) | 2.01063000 |
| 91 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00409723 |
| 92 | IgG deficiency (HP:0004315) | 2.00090877 |
| 93 | Tetraparesis (HP:0002273) | 1.98766325 |
| 94 | Abnormality of the preputium (HP:0100587) | 1.98293556 |
| 95 | Abnormality of the fingertips (HP:0001211) | 1.98047076 |
| 96 | Abnormality of glycolysis (HP:0004366) | 1.97501720 |
| 97 | Fatigue (HP:0012378) | 1.97230665 |
| 98 | Nonimmune hydrops fetalis (HP:0001790) | 1.95905702 |
| 99 | Ependymoma (HP:0002888) | 1.94289883 |
| 100 | Type I transferrin isoform profile (HP:0003642) | 1.93137284 |
| 101 | Amaurosis fugax (HP:0100576) | 1.92628102 |
| 102 | Myelodysplasia (HP:0002863) | 1.92206518 |
| 103 | Systemic lupus erythematosus (HP:0002725) | 1.92093298 |
| 104 | Osteomyelitis (HP:0002754) | 1.91694870 |
| 105 | Disinhibition (HP:0000734) | 1.91042254 |
| 106 | Abnormal number of incisors (HP:0011064) | 1.90035144 |
| 107 | Skin ulcer (HP:0200042) | 1.89264339 |
| 108 | Bone marrow hypocellularity (HP:0005528) | 1.88825149 |
| 109 | Granulocytopenia (HP:0001913) | 1.88774192 |
| 110 | Increased serum pyruvate (HP:0003542) | 1.88671815 |
| 111 | Increased IgE level (HP:0003212) | 1.87527586 |
| 112 | Reticulocytopenia (HP:0001896) | 1.86476084 |
| 113 | Urticaria (HP:0001025) | 1.86053755 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 1.85264095 |
| 115 | Colitis (HP:0002583) | 1.85144815 |
| 116 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84976143 |
| 117 | Periodontitis (HP:0000704) | 1.84839170 |
| 118 | Premature graying of hair (HP:0002216) | 1.84555871 |
| 119 | Spinal muscular atrophy (HP:0007269) | 1.83710051 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.83619460 |
| 121 | Abnormality of eosinophils (HP:0001879) | 1.81799026 |
| 122 | Prostate neoplasm (HP:0100787) | 1.78062207 |
| 123 | Birth length less than 3rd percentile (HP:0003561) | 1.77618233 |
| 124 | Panhypogammaglobulinemia (HP:0003139) | 1.77580435 |
| 125 | Gastrointestinal stroma tumor (HP:0100723) | 1.76877622 |
| 126 | Inflammation of the large intestine (HP:0002037) | 1.76657988 |
| 127 | Hemoptysis (HP:0002105) | 1.76538230 |
| 128 | Increased cerebral lipofuscin (HP:0011813) | 1.76217216 |
| 129 | Spontaneous hematomas (HP:0007420) | 1.75813011 |
| 130 | Recurrent pneumonia (HP:0006532) | 1.75702110 |
| 131 | Esophageal neoplasm (HP:0100751) | 1.75574548 |
| 132 | Neoplasm of head and neck (HP:0012288) | 1.75574548 |
| 133 | Reduced antithrombin III activity (HP:0001976) | 1.74227586 |
| 134 | Orthostatic hypotension (HP:0001278) | 1.74136701 |
| 135 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73512186 |
| 136 | Abnormal platelet function (HP:0011869) | 1.72601830 |
| 137 | Impaired platelet aggregation (HP:0003540) | 1.72601830 |
| 138 | Severe combined immunodeficiency (HP:0004430) | 1.71601675 |
| 139 | Secondary amenorrhea (HP:0000869) | 1.71360786 |
| 140 | Leukopenia (HP:0001882) | 1.70854942 |
| 141 | Sparse eyelashes (HP:0000653) | 1.70605299 |
| 142 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.70158973 |
| 143 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.70158973 |
| 144 | Anorexia (HP:0002039) | 1.69704990 |
| 145 | High pitched voice (HP:0001620) | 1.68299820 |
| 146 | Basal cell carcinoma (HP:0002671) | 1.68161992 |
| 147 | Albinism (HP:0001022) | 1.67935519 |
| 148 | Chest pain (HP:0100749) | 1.66863280 |
| 149 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.66857949 |
| 150 | Poikiloderma (HP:0001029) | 1.66498224 |
| 151 | Cholelithiasis (HP:0001081) | 1.66391462 |
| 152 | Plagiocephaly (HP:0001357) | 1.66317176 |
| 153 | Encephalitis (HP:0002383) | 1.65866197 |
| 154 | Breast hypoplasia (HP:0003187) | 1.65387056 |
| 155 | Progressive neurologic deterioration (HP:0002344) | 1.63179191 |
| 156 | Abnormal number of erythroid precursors (HP:0012131) | 1.62767601 |
| 157 | Gastrointestinal dysmotility (HP:0002579) | 1.62426347 |
| 158 | Acute hepatic failure (HP:0006554) | 1.62134943 |
| 159 | Hypopigmented skin patches (HP:0001053) | 1.60994343 |
| 160 | Cellular immunodeficiency (HP:0005374) | 1.60966471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.69660682 |
| 2 | MAP4K1 | 3.47042082 |
| 3 | TYK2 | 3.24470455 |
| 4 | SMG1 | 3.14583170 |
| 5 | ERN1 | 2.97393805 |
| 6 | JAK3 | 2.72084427 |
| 7 | TBK1 | 2.63300268 |
| 8 | STK10 | 2.61035717 |
| 9 | BLK | 2.57424497 |
| 10 | MAP3K10 | 2.44844541 |
| 11 | IKBKE | 2.41527152 |
| 12 | PIM2 | 2.41385875 |
| 13 | CDK12 | 2.30423770 |
| 14 | SRPK1 | 2.26446878 |
| 15 | MAP3K14 | 2.19138287 |
| 16 | TXK | 2.02442495 |
| 17 | TAF1 | 1.98909931 |
| 18 | ZAP70 | 1.97305270 |
| 19 | FGFR4 | 1.86275398 |
| 20 | IKBKB | 1.84913941 |
| 21 | JAK1 | 1.84325001 |
| 22 | IRAK4 | 1.81080271 |
| 23 | PRPF4B | 1.72309412 |
| 24 | CSK | 1.70292111 |
| 25 | RPS6KA4 | 1.67910601 |
| 26 | CDC7 | 1.67597710 |
| 27 | TSSK6 | 1.65797489 |
| 28 | KIT | 1.62163335 |
| 29 | PBK | 1.53261885 |
| 30 | FLT3 | 1.50348977 |
| 31 | TAOK2 | 1.46728233 |
| 32 | NEK2 | 1.46465264 |
| 33 | TRIB3 | 1.44302337 |
| 34 | PIM1 | 1.43582201 |
| 35 | NEK1 | 1.30443819 |
| 36 | CHUK | 1.30056614 |
| 37 | STK16 | 1.24051286 |
| 38 | EEF2K | 1.19675243 |
| 39 | NME2 | 1.18010571 |
| 40 | TESK2 | 1.16755289 |
| 41 | CLK1 | 1.16203503 |
| 42 | GRK6 | 1.15632621 |
| 43 | STK4 | 1.09010901 |
| 44 | LRRK2 | 1.08665303 |
| 45 | TESK1 | 1.07130154 |
| 46 | FGFR3 | 1.06576562 |
| 47 | MAP3K13 | 1.05902965 |
| 48 | DAPK1 | 1.04415567 |
| 49 | CDK4 | 1.03917485 |
| 50 | PKN2 | 1.02752116 |
| 51 | PLK3 | 1.00886999 |
| 52 | CDK7 | 0.97530802 |
| 53 | SYK | 0.97507180 |
| 54 | SIK3 | 0.96105699 |
| 55 | BTK | 0.95808235 |
| 56 | LCK | 0.95672621 |
| 57 | MAP3K8 | 0.95631900 |
| 58 | WEE1 | 0.95308353 |
| 59 | MAP3K11 | 0.93194841 |
| 60 | BRSK1 | 0.93097074 |
| 61 | * ATR | 0.92332885 |
| 62 | AURKA | 0.91209415 |
| 63 | VRK1 | 0.91153080 |
| 64 | CHEK2 | 0.90377852 |
| 65 | MATK | 0.90362657 |
| 66 | RIPK4 | 0.89710574 |
| 67 | CSF1R | 0.89482616 |
| 68 | BUB1 | 0.88823734 |
| 69 | PAK4 | 0.86871967 |
| 70 | ARAF | 0.86288295 |
| 71 | EIF2AK1 | 0.86158110 |
| 72 | ALK | 0.85027456 |
| 73 | BMPR2 | 0.83546009 |
| 74 | HCK | 0.83330016 |
| 75 | SCYL2 | 0.81917597 |
| 76 | MARK3 | 0.79706134 |
| 77 | MAP3K3 | 0.78789467 |
| 78 | IRAK3 | 0.78745175 |
| 79 | ICK | 0.75179178 |
| 80 | ZAK | 0.75057464 |
| 81 | PRKCI | 0.74200784 |
| 82 | LYN | 0.74116425 |
| 83 | EPHB1 | 0.72753623 |
| 84 | ITK | 0.72236182 |
| 85 | NME1 | 0.72187860 |
| 86 | PLK4 | 0.70729367 |
| 87 | KDR | 0.68036411 |
| 88 | RPS6KB2 | 0.67833150 |
| 89 | STK3 | 0.67784547 |
| 90 | PASK | 0.66988083 |
| 91 | JAK2 | 0.66820001 |
| 92 | EPHA3 | 0.65529830 |
| 93 | BMX | 0.63824830 |
| 94 | RIPK1 | 0.62966978 |
| 95 | RAF1 | 0.62601748 |
| 96 | BCKDK | 0.61997231 |
| 97 | NLK | 0.61893535 |
| 98 | SIK1 | 0.61568164 |
| 99 | MST4 | 0.59474280 |
| 100 | CDK9 | 0.58788477 |
| 101 | PLK1 | 0.57329320 |
| 102 | LIMK1 | 0.57119909 |
| 103 | PDGFRA | 0.56987931 |
| 104 | BRAF | 0.56027054 |
| 105 | DYRK3 | 0.55487310 |
| 106 | EIF2AK3 | 0.54295210 |
| 107 | TLK1 | 0.53617027 |
| 108 | CDK6 | 0.53616329 |
| 109 | NEK9 | 0.53418825 |
| 110 | EPHA2 | 0.53283712 |
| 111 | CHEK1 | 0.51624633 |
| 112 | MAPK11 | 0.51225621 |
| 113 | MTOR | 0.50008121 |
| 114 | CCNB1 | 0.49271614 |
| 115 | PTK6 | 0.48176483 |
| 116 | TTK | 0.47739976 |
| 117 | MAP2K3 | 0.46351700 |
| 118 | TAOK1 | 0.46015903 |
| 119 | PAK1 | 0.44642467 |
| 120 | FGR | 0.44545572 |
| 121 | IRAK1 | 0.44049577 |
| 122 | TRPM7 | 0.43613156 |
| 123 | RPS6KA1 | 0.42684536 |
| 124 | AURKB | 0.41019523 |
| 125 | MAPKAPK2 | 0.40879287 |
| 126 | TGFBR1 | 0.40161588 |
| 127 | TGFBR2 | 0.39425691 |
| 128 | CSNK2A2 | 0.38969917 |
| 129 | EGFR | 0.37882061 |
| 130 | EIF2AK2 | 0.37528104 |
| 131 | TEC | 0.36933108 |
| 132 | MELK | 0.36923072 |
| 133 | * ATM | 0.36878551 |
| 134 | KSR2 | 0.35931205 |
| 135 | RPS6KA5 | 0.35638257 |
| 136 | * CDK2 | 0.35446842 |
| 137 | RPS6KA6 | 0.34438393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.73361723 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.38547439 |
| 3 | Measles_Homo sapiens_hsa05162 | 2.36747150 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.32876493 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28434657 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.27230459 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.26487634 |
| 8 | * Herpes simplex infection_Homo sapiens_hsa05168 | 2.20913717 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10490468 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.08997653 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.06388448 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 2.00795140 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94331106 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.83115348 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.79331489 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.76298798 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66868481 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65861301 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61894583 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61467557 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61200069 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.58481710 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54123690 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53282915 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50692758 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45506873 |
| 27 | * Apoptosis_Homo sapiens_hsa04210 | 1.40405660 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40389519 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.40017782 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.38663890 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.38566016 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37941674 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32798010 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.30912527 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29442880 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.29102385 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.28686250 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.27064989 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.26831902 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.25532183 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24790758 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22045382 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21283951 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20894002 |
| 45 | Cell cycle_Homo sapiens_hsa04110 | 1.19920870 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.19619858 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18418058 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.15738508 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14983944 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14639301 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.09966485 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09006326 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08839618 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.07088703 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06966709 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.06681705 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03328573 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00710545 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98244150 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96852295 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95336013 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91980546 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91503816 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.90947790 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90751757 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90492195 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89721669 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88727435 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88166993 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.87786061 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.87687900 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87149760 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85757929 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83730936 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83728395 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83100179 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.81182426 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80295320 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77318319 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77053756 |
| 81 | Ribosome_Homo sapiens_hsa03010 | 0.75239837 |
| 82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74499820 |
| 83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71520930 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71355190 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70789125 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69760071 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69340400 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69308570 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68880868 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68427523 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66557855 |
| 92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66316421 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.65747469 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65073898 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64856981 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64825222 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64525393 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63245100 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61200040 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58485197 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55193177 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54095078 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53446031 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51779853 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50735428 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.50699452 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50072639 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49998979 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47997137 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45991452 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45839623 |
| 112 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45617023 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43404045 |
| 114 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41610242 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.40207946 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.39396758 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38830086 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38153553 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37087563 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.36956653 |
| 121 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36108195 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35845343 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35160520 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34970739 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34676809 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33540362 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33194861 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32761433 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31880291 |

